Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer

Overview of attention for article published in Clinical Cancer Research, October 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#8 of 17,708)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 53 news outlets
blogs: 4 blogs
twitter: 226 X users

facebook: 5 Facebook pages
wikipedia: 5 Wikipedia pages
reddit: 4 Redditors

Readers on

mendeley: 89 Mendeley

So far, Altmetric has seen 62 news stories from 53 outlets.

Let's Talk About Bladder Cancer

Health Central, 20 Oct 2021

Whether you’ve just been diagnosed or worry you could have bladder cancer, you’re probably nervous, confused, and maybe even a…

Let's Talk About What Causes Bladder Cancer

Health Central, 20 Oct 2021

Here’s a stat you probably didn’t know: One in 40 people will get bladder cancer at some point during their lives.

Common cold virus could transform bladder cancer treatment

Healio.com, 23 Sep 2019

Nicola E. Annels A novel therapeutic approach that involves the oncolytic virus coxsackievirus showed potential among a small…

CANCER de la VESSIE : Un virus du rhume pour en venir à bout ?

Santé blog, 23 Aug 2019

Cette découverte d’une équipe de l’Université de Surrey pourrait révolutionner le traitement du cancer de la vessie : une…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 58 additional news stories.